Ally Bridge Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$4.5M Hold
2022
Q1
$7.04M Sell
2021
Q4
$15.8M Hold
2021
Q3
$16M Hold
2021
Q2
$23.4M Hold
2021
Q1
$22.3M Buy
2020
Q4
$23.6M Buy